| RS1265323526 |
SLC18A2
|
Health Risk |
Pathogenic |
Brain dopamine-serotonin vesicular transport disease, Brain dopamine-serotonin vesicular transport disease |
| RS1265333590 |
SLC2A9
|
Health Risk |
Likely pathogenic |
SLC2A9-related disorder, SLC2A9-related disorder |
| RS1265340906 |
GRIK2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1265352306 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS1265352633 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of breast, Hereditary breast ovarian cancer syndrome |
| RS1265366427 |
ORAI1
|
Health Risk |
Likely pathogenic |
Myopathy, tubular aggregate |
| RS1265368591 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1265369157 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 11 |
| RS1265370991 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Elevated circulating creatine kinase concentration |
| RS1265375100 |
UBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1265381182 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2C |
| RS1265382491 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1265391373 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1265410646 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Hyperinsulinemic hypoglycemia |
| RS1265411161 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1265421045 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS12654264 |
HMGCR
|
Health Risk |
association |
Low density lipoprotein cholesterol level quantitative trait locus 3, Low density lipoprotein cholesterol level quantitative trait locus 3 |
| RS1265437249 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1265456777 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1265464096 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1265493319 |
CHRNG
|
Health Risk |
Pathogenic |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1265536815 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Hereditary cancer-predisposing syndrome |
| RS1265544300 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1265547595 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1265561583 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1265596566 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1265628439 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1265632174 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1265642949 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Alagille syndrome due to a JAG1 point mutation |
| RS1265655451 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1265658401 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Inborn genetic diseases |
| RS1265664823 |
TAPT1
|
Health Risk |
Likely pathogenic |
Complex lethal osteochondrodysplasia, Complex lethal osteochondrodysplasia |
| RS1265669915 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1265678329 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALS2-related disorder, Amyotrophic lateral sclerosis type 2 |
| RS1265680220 |
PDE6A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1265683288 |
RUSC2
|
Health Risk |
Pathogenic |
— |
| RS1265717222 |
HNF1A
|
Health Risk |
Likely risk allele |
Type 2 diabetes mellitus, Maturity-onset diabetes of the young |
| RS1265727354 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1265748598 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis 4 |
| RS1265764649 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfate transporter-related osteochondrodysplasia, Achondrogenesis |
| RS1265774517 |
DAW1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Ciliary dyskinesia |
| RS1265790137 |
USP53
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Cholestasis |
| RS1265809314 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 3, Cardiofaciocutaneous syndrome 3 |
| RS1265812765 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1265814223 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic hearing loss, Monogenic hearing loss |
| RS1265832990 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1265840106 |
ABCA4
|
Health Risk |
Pathogenic |
Age related macular degeneration 2, Severe early-childhood-onset retinal dystrophy |
| RS1265868770 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1265892085 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1265895182 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1265902011 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1265911468 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1265949362 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS1265969343 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS1266041812 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1266042922 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1266047546 |
TCOF1
|
Health Risk |
Likely pathogenic |
— |
| RS1266051315 |
ERCC2
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS1266053680 |
ABCC8
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Hyperinsulinemic hypoglycemia |
| RS1266064055 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS1266068657 |
TRPV6
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism, transient neonatal |
| RS1266078341 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1266090046 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1266098984 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1266102026 |
REEP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1266104510 |
NCSTN
|
Health Risk |
Pathogenic |
— |
| RS1266114717 |
MALT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS1266152010 |
PCNT
|
Health Risk |
Pathogenic |
PCNT-related disorder, PCNT-related disorder |
| RS1266187397 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis multiplex congenita 6, Nemaline myopathy 2 |
| RS1266192229 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 9 |
| RS1266192644 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1266198754 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1266206916 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS1266211447 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1266229950 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis 1 |
| RS1266240114 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1266242324 |
TSEN54
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 5 |
| RS1266250537 |
PAX1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1266251678 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1266259634 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1266265578 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1266288524 |
KLK4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS1266294051 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1266297781 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1266298136 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1266313425 |
ARSG
|
Health Risk |
Pathogenic |
— |
| RS1266327660 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1266345519 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS1266348463 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1266350933 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMA5-related disorder |
| RS1266358260 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1266361856 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease type 2A2 |
| RS1266363944 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis, Retinitis pigmentosa 12 |
| RS1266375962 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS1266378538 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1266389046 |
RXYLT1
|
Health Risk |
Pathogenic |
— |
| RS1266397026 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1266443165 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Autosomal dominant nonsyndromic hearing loss 11 |
| RS1266458783 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1266489077 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |